Nuclear transport of phosphorylated LanCL2 promotes invadopodia formation and tumor progression of glioblastoma by activating STAT3/Cortactin signaling.
Saved in:
| Title: | Nuclear transport of phosphorylated LanCL2 promotes invadopodia formation and tumor progression of glioblastoma by activating STAT3/Cortactin signaling. |
|---|---|
| Authors: | Zhao HF; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address: zhaohf0416@email.szu.edu.cn., Liu YS; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China., Wang J; Department of Neurosurgery/Neuro-oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China., Wu CP; Department of Neurosurgery, Shenzhen Longhua New District People's Hospital, Shenzhen 518109, China., Zhou XM; Epilepsy Center, Guangdong 999 Brain Hospital, Guangzhou 510510, China., Cai LR; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China., Liu J; Department of Pathology, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China., Liu XJ; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China., Xu YW; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China., Li WP; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China., Huang GD; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address: huangguodong@email.szu.edu.cn. |
| Source: | Journal of advanced research [J Adv Res] 2025 Mar; Vol. 69, pp. 139-155. Date of Electronic Publication: 2024 Mar 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cairo University, production and hosting by Elsevier B. V Country of Publication: Egypt NLM ID: 101546952 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2090-1224 (Electronic) Linking ISSN: 20901224 NLM ISO Abbreviation: J Adv Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38492734 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Nuclear transport of phosphorylated LanCL2 promotes invadopodia formation and tumor progression of glioblastoma by activating STAT3/Cortactin signaling. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhao+HF%22">Zhao HF</searchLink>; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address: zhaohf0416@email.szu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Liu+YS%22">Liu YS</searchLink>; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Neurosurgery/Neuro-oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.<br /><searchLink fieldCode="AU" term="%22Wu+CP%22">Wu CP</searchLink>; Department of Neurosurgery, Shenzhen Longhua New District People's Hospital, Shenzhen 518109, China.<br /><searchLink fieldCode="AU" term="%22Zhou+XM%22">Zhou XM</searchLink>; Epilepsy Center, Guangdong 999 Brain Hospital, Guangzhou 510510, China.<br /><searchLink fieldCode="AU" term="%22Cai+LR%22">Cai LR</searchLink>; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Department of Pathology, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China.<br /><searchLink fieldCode="AU" term="%22Liu+XJ%22">Liu XJ</searchLink>; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China.<br /><searchLink fieldCode="AU" term="%22Xu+YW%22">Xu YW</searchLink>; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China.<br /><searchLink fieldCode="AU" term="%22Li+WP%22">Li WP</searchLink>; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China.<br /><searchLink fieldCode="AU" term="%22Huang+GD%22">Huang GD</searchLink>; Department of Neurosurgery, Institute of Translational Medicine, Shenzhen University First Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen 518035, China. Electronic address: huangguodong@email.szu.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101546952%22">Journal of advanced research</searchLink> [J Adv Res] 2025 Mar; Vol. 69, pp. 139-155. <i>Date of Electronic Publication: </i>2024 Mar 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cairo+University%2C+production+and+hosting+by+Elsevier+B%2E+V%22">Cairo University, production and hosting by Elsevier B. V </searchLink><i>Country of Publication: </i>Egypt <i>NLM ID: </i>101546952 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2090-1224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220901224%22">20901224 </searchLink><i>NLM ISO Abbreviation: </i>J Adv Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38492734 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jare.2024.03.007 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 139 Titles: – TitleFull: Nuclear transport of phosphorylated LanCL2 promotes invadopodia formation and tumor progression of glioblastoma by activating STAT3/Cortactin signaling. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhao HF – PersonEntity: Name: NameFull: Liu YS – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Wu CP – PersonEntity: Name: NameFull: Zhou XM – PersonEntity: Name: NameFull: Cai LR – PersonEntity: Name: NameFull: Liu J – PersonEntity: Name: NameFull: Liu XJ – PersonEntity: Name: NameFull: Xu YW – PersonEntity: Name: NameFull: Li WP – PersonEntity: Name: NameFull: Huang GD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2025 Mar Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2090-1224 Numbering: – Type: volume Value: 69 Titles: – TitleFull: Journal of advanced research Type: main |
| ResultId | 1 |
